JPS5782319A - Antitumor agent - Google Patents

Antitumor agent

Info

Publication number
JPS5782319A
JPS5782319A JP55156418A JP15641880A JPS5782319A JP S5782319 A JPS5782319 A JP S5782319A JP 55156418 A JP55156418 A JP 55156418A JP 15641880 A JP15641880 A JP 15641880A JP S5782319 A JPS5782319 A JP S5782319A
Authority
JP
Japan
Prior art keywords
glucopyranosyl
ginseng
antitumor agent
panax
constituent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP55156418A
Other languages
Japanese (ja)
Inventor
Kiyokubai Gen
Akihiro Yamamura
Kanjiyun Chiyou
Ryuta Ito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ITO RIYUUTA
Original Assignee
ITO RIYUUTA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ITO RIYUUTA filed Critical ITO RIYUUTA
Priority to JP55156418A priority Critical patent/JPS5782319A/en
Publication of JPS5782319A publication Critical patent/JPS5782319A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE: An antitumor agent containing a saponin constituent in the terrestrial part of a medicinal ginseng as an active constituent, and suitable for the oral administration without exhibiting the toxicity and hemolytic action.
CONSTITUTION: An antitumor agent containing a saponin constituent in the terrestrial part of a medicinal ginseng, e.g. panax ginseng C.A. Meyer, Panax japonicus C.A. Meyer or Panax quinquefolium Linne. The saponin constituent consists of ginsenosides expressed by formulasI, II and III [R1 is β-D-glucopyranosyl (1→ 2)-β-D-glucopyranosyl; R2 is β-D-glucopyranosyl(1→6)-β-D-glucopyranosyl, etc.; R3 is α-L-rhamnopyranosyl(1→2)-β-D-glucopyranosyl, etc.; R4 is H or β-D-glucopyranosyl; R5 is β-D-glucopyranosyl; R6 is β-D-glucopyranosyl(1→2)- β-D-glucopyranosyl]. These ginsenosides are obtained by extracting the terrestrial part of the ginseng as a raw material with a solvent, separating and purifying the resultant extract.
COPYRIGHT: (C)1982,JPO&Japio
JP55156418A 1980-11-06 1980-11-06 Antitumor agent Pending JPS5782319A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP55156418A JPS5782319A (en) 1980-11-06 1980-11-06 Antitumor agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55156418A JPS5782319A (en) 1980-11-06 1980-11-06 Antitumor agent

Publications (1)

Publication Number Publication Date
JPS5782319A true JPS5782319A (en) 1982-05-22

Family

ID=15627315

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55156418A Pending JPS5782319A (en) 1980-11-06 1980-11-06 Antitumor agent

Country Status (1)

Country Link
JP (1) JPS5782319A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0787496A1 (en) * 1996-01-31 1997-08-06 ABOCA di Mercati Valentino & C. S.A.S. Process through which to obtain multifraction dry extracts from plants
JP2005531576A (en) * 2002-05-28 2005-10-20 エムディー バイオアルファ カンパニー リミテッド Fractions with anticancer and antimetastatic activity from carrot leaves and stems
JP2006119089A (en) * 2004-10-25 2006-05-11 Sokkia Co Ltd Light wave range finder
CN104306418A (en) * 2014-10-21 2015-01-28 重庆芸峰药业有限公司 Optimized process for extracting ginseng
JP2016521743A (en) * 2013-06-11 2016-07-25 ユニバーシテイー‐インダストリー コオペレーション グループ オブ キュンヒー ユニバーシテイー Anticancer composition containing a mixed herbal extract as an active ingredient
CN105852130A (en) * 2016-05-24 2016-08-17 朱启标 Preparation method of ginseng health care product and product of preparation method

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0787496A1 (en) * 1996-01-31 1997-08-06 ABOCA di Mercati Valentino & C. S.A.S. Process through which to obtain multifraction dry extracts from plants
JP2005531576A (en) * 2002-05-28 2005-10-20 エムディー バイオアルファ カンパニー リミテッド Fractions with anticancer and antimetastatic activity from carrot leaves and stems
JP2011093928A (en) * 2002-05-28 2011-05-12 Md Bioalpha Co Ltd Fraction obtained from leaf and stem of genus panax having anticancer and antimetastatic activity
JP2006119089A (en) * 2004-10-25 2006-05-11 Sokkia Co Ltd Light wave range finder
JP2016521743A (en) * 2013-06-11 2016-07-25 ユニバーシテイー‐インダストリー コオペレーション グループ オブ キュンヒー ユニバーシテイー Anticancer composition containing a mixed herbal extract as an active ingredient
CN104306418A (en) * 2014-10-21 2015-01-28 重庆芸峰药业有限公司 Optimized process for extracting ginseng
CN105852130A (en) * 2016-05-24 2016-08-17 朱启标 Preparation method of ginseng health care product and product of preparation method

Similar Documents

Publication Publication Date Title
Yoshikawa et al. Bioactive saponins and glycosides. VIII. Notoginseng (1): new dammarane-type triterpene oligoglycosides, notoginsenosides-A,-B,-C, and-D, from the dried root of Panax notoginseng (Burk.) FH Chen
IL84135A0 (en) 9-alpha-hydroxy steroids,process for their preparation,process for the preparation of the corresponding 9(11)-dehydro derivatives and pharmaceutical preparations containing said steroids
JPS56160962A (en) Purification of solution containing stevioside-type sweetening substance
IE831164L (en) Pharmaceutical preparations containing sesquiterpene¹lactones
JPS56135416A (en) Pharmaceutical preparation for skin
ES8207217A1 (en) Alpha-amylase inactivator, process for its preparation, composition containing said inactivator, and this inactivator for the regulation of the blood sugar level.
PT81347A (en) Method for the preparation of pharmaceutical compositions containing anthracycline glycosides
JPS5626818A (en) Glucocorticoid drug
JPS5782319A (en) Antitumor agent
JPS6468318A (en) Prophylactic improver or hepatic function disorder
KR910005879A (en) Pharmaceutical preparations and methods for producing new anticancer activity
EP1340502A3 (en) Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
JPS536413A (en) Preparation of n-containing polysaccharides
Sandberg TWO GLYCOSIDE–CONTAINING GENERA OF THE ARALIACEAE FAMILY PANAX AND ELEUTHEROCOCCUS1
EP0715517A4 (en) Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
JPS55122724A (en) Antidiabetic agent
JPS5430146A (en) Novel anthracycline derivatives and their preparation
FR2430234A1 (en) Antitumour compsn. contg. Panax saponin - esp. from Panax ginseng
JPS5533456A (en) Separation of ginseng saponin
IL101908A (en) Process for extraction of antineoplastic substances from plants of the family pittosporaceae, extracts obtained thereby, and pharmaceutical preparations containing them
CA2093914A1 (en) Antineoplastic drug of plant extraction and process for the preparation thereof
IL63287A0 (en) Anthracycline glycosides,their preparation and pharmaceutical compositions containing them
JPS55122721A (en) Antidiabetic agent
ZA796194B (en) New 2,2-dimethyl 19-nor steroid derivatives,process for their preparation,their application as medicaments and pharmaceutical compositions containing them
JPS56158800A (en) Preparation of saponins